Goscé, Lara; Pescarini, Julia M; Houben, Rein MGJ; McQuaid, Christopher Finn; (2025) Tuberculosis and the climate crisis in Latin America: a predicament of poverty, migration and displacement. BMJ global health, 10 (4). e018674-e018674. ISSN 2059-7908 DOI: https://doi.org/10.1136/bmjgh-2024-018674

Kuksa, L; Andrejak, C; Haecker, B; Bothamley, G; Calcagno, A; Cirillo, DM; Duarte, R; Fatima, R; Ferlazzo, G; Guglielmetti, L; +15 more... Günther, G; Hewison, C; Horsburgh, CR; Jäger, T; Kalancha, Y; Otto-Knapp, R; Kranzer, K; Lillebaek, T; Marks, G; Middelkoop, K; Motta, I; Rabinova, V; Sommerfeld, P; Tattevin, P; Lange, C; (2025) Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy. IJTLD open, 2 (3). pp. 117-119. ISSN 3005-7590 DOI: https://doi.org/10.5588/ijtldopen.25.0152

Madden, Norma; Tadesse, Amare W; Leung, Chung Lam; Gonçalves Tasca, Bianca; Alacapa, Jason; Deyanova, Natasha; Ndlovu, Nontobeko; Mokone, Nontobeko; Onjare, Baraka; Mganga, Andrew; +3 more... van Kalmthout, Kristian; Jerene, Degu; Fielding, Katherine; (2025) Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries. Tropical medicine and infectious disease, 10 (3). ISSN 2414-6366 DOI: https://doi.org/10.3390/tropicalmed10030068

Nassuuna, Jacent; Sterk, Joas; Walusimbi, Bridgious; Natukunda, Agnes; Nkangi, Ronald; Amongin, Rebecca; Zirimenya, Ludoviko; Webb, Emily L; Elliott, Alison M; Nkurunungi, Gyaviira; (2025) Helminth driven gut inflammation and microbial translocation associate with altered vaccine responses in rural Uganda. NPJ Vaccines, 10 (1). 56-. DOI: https://doi.org/10.1038/s41541-025-01116-x

Nguenha, D; Ndebele, F; Saavedra, B; Mambuque, E; Acácio, S; Cárdenas, V; Chihota, V; Grant, A; Yimer, G; Fielding, K; +3 more... Cobelens, F; Churchyard, G; Garcia-Basteiro, AL; (2025) BMI as a predictor of progression from TB infection to active TB in PLHIV. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 29 (2). pp. 54-59. ISSN 1027-3719 DOI: https://doi.org/10.5588/ijtld.24.0287

Sitenda, Diana; Ssekamatte, Phillip; Nakavuma, Rose; Kyazze, Andrew Peter; Bongomin, Felix; Baluku, Joseph Baruch; Nabatanzi, Rose; Kibirige, Davis; Wilkinson, Robert J; Nakimuli, Annettee; +2 more... Cose, Stephen; Andia-Biraro, Irene; (2025) Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda. BMC immunology, 26 (1). 13-. ISSN 1471-2172 DOI: https://doi.org/10.1186/s12865-025-00692-w

Sweeney, Sedona; Laurence, Yoko V; Berry, Catherine; Singh, Maninder Pal; Dodd, Matthew; Fielding, Katherine; Kazounis, Emil; Moodliar, Ronelle; Solodovnikova, Varvara; Tigay, Zinaida; +13 more... Liverko, Irina; Parpieva, Nargiza; Butabekov, Ilhomjon; Usmanova, Ruzilya; Rassool, Mohammed; Motta, Ilaria; Nyangweso, George Mokua; Jolivet, Pascal; Abdrasuliev, Tleubergen; Moe, Soe; Aw, Pei Sun; Samieva, Nazgul; Nyang'wa, Bern-Thomas; (2025) 24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation. The Lancet Global Health, 13 (2). e355-e363. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(24)00467-4

Yates, Tom A; Grint, Daniel J; (2025) Primary efficacy endpoints in phase 3 non-inferiority trials to establish new tuberculosis treatment regimens should only include microbiological outcomes. The Lancet microbe. 101117-. ISSN 2666-5247 DOI: https://doi.org/10.1016/j.lanmic.2025.101117

de Souza, Ramon Andrade; Barreto, Florisneide Rodrigues; de Jesus Lima, Carla Cristina Oliveira; da Natividade, Marcio Santos; de Souza Teles Santos, Carlos Antônio; Ichihara, Maria Yury; Pereira, Marcos; de Castro, Daniel Barros; Genser, Bernd; Rodrigues, Laura Cunha; +2 more... Barreto, Maurício Lima; Pereira, Susan Martins; (2025) Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: A BCG-REVAC population analysis. Vaccine, 54. 126911-. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2025.126911